Appointment booking for Dr. Tyler Zachary, MD is currently not available.Dr. Tyler Zachary, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Tyler Zachary, MD (he/him) is a Internist in Jackson, MS with over 9 years of experience. What is your opinion of Dr. Tyler Zachary, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 9 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Tyler Zachary, MD has received over $2,804 which includes payments from the following companies:
$1,424.57 from Novo Nordisk Inc
$167.64 from AstraZeneca Pharmaceuticals LP
$134.33 from Pfizer Inc.
$129.42 from LILLY USA, LLC
$110.46 from Merck Sharp & Dohme Corporation
$100.45 from Amgen Inc.
$85.78 from Shire North American Group Inc
$83.17 from AbbVie, Inc.
$67.20 from INSULET CORPORATION
$64.19 from Gilead Sciences Inc
$62.46 from Ultragenyx Pharmaceutical Inc.
$59.80 from Valeant Pharmaceuticals North America LLC
$58.95 from Corcept Therapeutics
$58.69 from sanofi-aventis U.S. LLC
$47.12 from Eisai Inc.
$34.88 from Boehringer Ingelheim Pharmaceuticals, Inc.
$27.89 from Radius Health, Inc.
$24.69 from Dexcom, Inc.
$24.32 from Tandem Diabetes Care, Inc.
$14.17 from Esperion Therapeutics, Inc.
Payments received by Dr. Tyler Zachary, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!